Welcome to our dedicated page for AGCB news (Ticker: AGCB), a resource for investors and traders seeking the latest updates and insights on AGCB stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AGCB's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AGCB's position in the market.
Altimeter Growth Corp. 2 (AGCB) announced its inability to finalize a business combination within the required time frame, leading to plans for dissolution and liquidation. The company will redeem all Class A common stock shares from its initial public offering at approximately $10.11 per share. This redemption process is expected to be completed by December 21, 2022, with shares deemed canceled upon redemption. The trust account will be liquidated for fund disbursement, while record holders can redeem shares through the transfer agent, with beneficial owners in 'street name' receiving the redemption automatically.
Infogain has appointed Anita Lynch and John Strain to its Board of Directors, enhancing its leadership team. Lynch brings over 25 years of experience in data and analytics, previously serving at major firms like Disney and Amazon. Strain, with more than 30 years in digital business, was previously Chief Digital Officer at The Gap, where he launched a successful loyalty program. Their appointments aim to boost Infogain's AI integration and client expansion in digital platform engineering.
Altimeter Growth Corp 2 (AGC 2) has priced its initial public offering of 40,000,000 Class A ordinary shares at $10.00 each, intending to raise $400 million. The shares will trade under the ticker 'AGCB' on the New York Stock Exchange starting January 7, 2021, with the closing of the IPO set for January 11, 2021. AGC 2 has also arranged a forward purchase agreement for up to 5,000,000 additional shares. The IPO was facilitated by Citigroup, Goldman Sachs, and Morgan Stanley, who have a 45-day option to purchase more shares to cover over-allotments.
FAQ
What is the market cap of AGCB (AGCB)?
